Sanjay Srivasta
Type 2 Diabetes (T2D) is a chronic metabolic disorder characterized by
hyperglycemia resulting from insulin resistance and impaired insulin
secretion. Effective pharmacologic management is essential for preventing
complications such as cardiovascular disease, nephropathy, neuropathy,
and retinopathy. This article provides an overview of the pharmacological
agents used in the management of T2D, including the role of insulin, oral
agents, and newer classes of drugs like GLP-1 receptor agonists and
SGLT2 inhibitors. The mechanisms, efficacy, safety profiles, and clinical
applications of these therapies are discussed. Additionally, the importance
of individualized treatment plans, patient education, and monitoring are
emphasized to achieve optimal glycemic control.
